Structures by: Attia M. I.
Total: 16
1-{[(2,3-Dihydro-1<i>H</i>-inden-2-yl)oxy]methyl}quinazoline- 2,4(1<i>H</i>,3<i>H</i>)-dione
C18H16N2O3
Acta Crystallographica Section E (2012) 68, 6 o1866-o1867
a=7.6684(8)Å b=10.0717(10)Å c=10.6748(11)Å
α=87.199(8)° β=78.332(8)° γ=70.569(8)°
5-Methoxy-2-[(5-methoxy-1<i>H</i>-indol-1-yl)carbonyl]-1<i>H</i>-indole
C19H16N2O3
Acta Crystallographica Section E (2012) 68, 6 o1775
a=11.3153(4)Å b=12.1183(5)Å c=17.1300(6)Å
α=76.251(3)° β=79.747(3)° γ=88.913(3)°
2-[(Cyclohex-3-en-1-ylmethoxy)methyl]-6-phenyl-1,2,4-triazine- 3,5(2<i>H</i>,4<i>H</i>)-dione
C17H19N3O3
Acta Crystallographica Section E (2012) 68, 6 o1776-o1777
a=4.7924(6)Å b=13.7083(19)Å c=11.8293(15)Å
α=90.00° β=101.538(12)° γ=90.00°
(<i>E</i>)-<i>N</i>-[3-(Imidazol-1-yl)-1-phenylpropylidene]hydroxylamine
C12H13N3O
Acta Crystallographica Section E (2012) 68, 3 o627
a=8.09900(10)Å b=14.0513(2)Å c=9.9771(2)Å
α=90.00° β=93.0580(10)° γ=90.00°
3-(1<i>H</i>-Imidazol-1-yl)-1-phenylpropan-1-ol
C12H14N2O
Acta Crystallographica Section E (2012) 68, 3 o628
a=9.0352(5)Å b=11.8521(7)Å c=10.3462(6)Å
α=90.00° β=109.6880(10)° γ=90.00°
<i>N</i>-Phenyl-2-(propan-2-ylidene)hydrazinecarboxamide
C10H13N3O
Acta Crystallographica Section E (2012) 68, 3 o671
a=6.2225(3)Å b=15.3429(7)Å c=11.8897(5)Å
α=90.00° β=112.283(4)° γ=90.00°
(<i>E</i>)-1-(1,3-Benzodioxol-5-yl)-4,4-dimethylpent-1-en-3-one
C14H16O3
Acta Crystallographica Section E (2012) 68, 3 o634
a=6.53050(10)Å b=6.67980(10)Å c=13.7264(2)Å
α=90.00° β=96.6760(10)° γ=90.00°
5-(Adamantan-1-yl)-3-[(4-benzylpiperazin-1-yl)methyl]-1,3,4-oxadiazole- 2(3<i>H</i>)-thione
C24H32N4O1S1
Acta Crystallographica Section E (2012) 68, 7 o2172-o2173
a=11.6417(9)Å b=17.198(2)Å c=12.7740(10)Å
α=90.00° β=115.060(10)° γ=90.00°
5-Methoxy-1-[(5-methoxy-1<i>H</i>-indol-2-yl)methyl]-1<i>H</i>-indole
C19H18N2O2
Acta Crystallographica Section E (2012) 68, 4 o971
a=9.4446(5)Å b=19.5625(8)Å c=8.6657(5)Å
α=90.00° β=98.903(4)° γ=90.00°
6-(3,5-Dimethylbenzyl)-5-ethyl-1-[(2-phenylethoxy)methyl]pyrimidine-2,4(1<i>H</i>,3<i>H</i>)dione
C24H28N2O3
Acta Crystallographica Section E (2012) 68, 4 o1031-o1032
a=8.343100(10)Å b=8.477600(10)Å c=15.9821(2)Å
α=91.56600(10)° β=91.78200(10)° γ=109.83500(10)°
1-{(<i>E</i>)-[3-(1<i>H</i>-Imidazol-1-yl)-1-(4- methoxyphenyl)propylidene]amino}-3-(2-methylphenyl)urea
C21H23N5O2
Acta Crystallographica Section E (2012) 68, 6 o1799-o1800
a=10.7798(12)Å b=20.7750(19)Å c=8.7652(18)Å
α=90.00° β=105.318(15)° γ=90.00°
6-(4-Bromophenyl)-3-methyl-7<i>H</i>-1,2,4- triazolo[3,4-<i>b</i>][1,3,4]thiadiazine
C11H9BrN4S
Acta Crystallographica Section E (2012) 68, 6 o1681
a=4.0047(10)Å b=13.424(3)Å c=10.938(3)Å
α=90.00° β=99.650(5)° γ=90.00°
6-Methyl-1-({[(2<i>E</i>)-2-methyl-3-phenylprop-2-en-1-yl]oxy}methyl)- 1,2,3,4-tetrahydroquinazoline-2,4-dione
C20H20N2O3
Acta Crystallographica Section E (2012) 68, 6 o1768-o1769
a=16.2352(8)Å b=13.6934(6)Å c=7.8900(4)Å
α=90.00° β=102.606(5)° γ=90.00°
6-Chloro-1-({[(2<i>E</i>)-2-methyl-3-phenylprop-2-en-1-yl]oxy}methyl)- 1,2,3,4-tetrahydroquinazoline-2,4-dione
C19H17ClN2O3
Acta Crystallographica Section E (2012) 68, 6 o1770-o1771
a=7.6179(3)Å b=9.8168(4)Å c=11.7009(6)Å
α=73.937(4)° β=83.651(3)° γ=80.942(3)°
1-{(<i>E</i>)-[3-(1<i>H</i>-Imidazol-1-yl)-1-phenylpropylidene]amino}-3-(2- methylphenyl)urea
C20H21N5O
Acta Crystallographica Section E (2012) 68, 6 o1848-o1849
a=20.5220(17)Å b=14.1916(11)Å c=6.0060(4)Å
α=90.00° β=90.00° γ=90.00°
2-(2,3-Dimethylanilino)benzohydrazide
C15H17N3O
Acta Crystallographica Section E (2012) 68, 8 o2527-o2528
a=6.9092(8)Å b=6.9609(7)Å c=14.9458(15)Å
α=81.562(2)° β=81.328(2)° γ=66.269(2)°